HANSOH PHARMAC. HD-00001 (3KY) — Net Asset Quality Index
HANSOH PHARMAC. HD-00001 (3KY) has a Net Asset Quality Index of 88.6% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €39.90 Billion minus total liabilities of €4.54 Billion yields net assets of €35.36 Billion. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see 3KY market cap overview.
Quality Index
Net Assets
Total Assets
Total Liabilities
HANSOH PHARMAC. HD-00001 Net Asset Quality Index Over Time (2021–2025)
This chart shows how HANSOH PHARMAC. HD-00001's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 88.6%, representing net assets of €35.36 Billion against total assets of €39.90 Billion EUR. See HANSOH PHARMAC. HD-00001 net assets for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for HANSOH PHARMAC. HD-00001 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for HANSOH PHARMAC. HD-00001 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Also explore 3KY shareholders equity momentum to track the company's year-over-year net asset growth rate.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.6% | €35.36 Billion | €39.90 Billion | €4.54 Billion | ▼ -2.0 pp |
| 2024 | 90.6% | €28.68 Billion | €31.66 Billion | €2.98 Billion | ▲ +12.5 pp |
| 2023 | 78.1% | €25.79 Billion | €33.04 Billion | €7.24 Billion | ▲ +2.6 pp |
| 2022 | 75.5% | €22.65 Billion | €30.00 Billion | €7.35 Billion | ▲ +1.7 pp |
| 2021 | 73.7% | €20.03 Billion | €27.16 Billion | €7.13 Billion | — |